Keeping Honest in Healthcare: Engineering Accountability into AI
When AI is honest and acts as a connector in healthcare workflows, clinician time is freed up, accuracy is ensured, and revenue is protected.
The Critical Challenges Facing Post-Acute Care and Why Agentic AI Is No Longer Optional
The real value of AI in post-acute care is not how quickly it can process documents, but whether it can provide foresight. That means understanding how clinical indicators, regulatory requirements, and reimbursement rules interact, and identifying risk before it turns into a denial or an audit finding.
The Digital Health M&A Wave Is Finally Here
Digital health is entering a more mature phase in 2026 as consolidation accelerates through targeted M&A, driven by the need for scale, artificial intelligence and pressure from payers, investors say.
Do Ambient Scribe Startups Have a Future Now That Epic Launched Its Own Tool?
Epic’s rollout of a built-in AI charting tool is intensifying competition in the already crowded ambient AI scribe market, forcing standalone vendors to sharpen their differentiation in an Epic-dominated health system landscape.
Eikon Therapeutics Continues the IPO Parade, Raising $381M for Cancer Drug Clinical Trials
Eikon Therapeutics’ IPO haul will support a lead program that could expand the scope of cancer immunotherapy. Eikon’s stock market debut builds on growing IPO momentum, following upsized offerings from Aktis Oncology and Veradermics.